State Stem Cell Agency ICOC Agenda 12-09-08

INDEPENDENT CITIZENS OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To Government Code section 11346.5(a)(17)
and
The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Open Session

1. Call to Order.
2. Pledge of Allegiance.
3. Roll Call.

   [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

CONSENT ITEMS

4. Approval of minutes from August 12-13 and September 25th, 2008 ICOC Meetings.

Reports

5. Chairman’s Report.
6. President’s Report.
7. Informational update on status of the Intellectual Property Policy Consolidation project.

ACTION ITEMS

8. Consideration of recommendations from Grants Working Group on Tools and Technology Award applications.
9. Consideration of recommendation from Grants Working Group on New Cell Lines application.

closed session

10. Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data relating to Tools and Technology applications and New Cell Lines application. (Health & Safety Code 125290.30(d) (3) (B) and (C)).

ACTION ITEMS

11. Public report of any action taken, if necessary, during closed session.
12. Consideration of CIRM Strategic Plan revision, including but not limited to stakeholder and public comment process
13. Consideration of concept plan for Disease Team Research Award RFA.

closed session

14. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

ACTION ITEMS

15. Public report of any action taken, if necessary, during closed session.
16. Consideration of compensation of Chair of the ICOC.
    1. Additional Information: Letter from Governor
17. Consideration of concept plan for Basic Research Initiative
18. Consideration of approval for staff to finalize regulations process for amendments to the Grants Administration Policy for Academic and Non-Profit Institutionsand submission of amendments to the OAL for final approval.
    1. Regulation 100500 amendments.
19. Consideration of names for CIRM funded Major Facilities.
20. Consideration of Pre-Application Review.
21. Consideration of CIRM Conference Grant Application from the International Society for Stem Cell Research.
22. Consideration of appointment of new scientific members for Grants Working Group.
23. Consideration of accelerated funding program for approved grants and loans for for-profits.
24. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.